Viewing Study NCT05261269


Ignite Creation Date: 2025-12-24 @ 10:56 PM
Ignite Modification Date: 2026-01-01 @ 10:24 PM
Study NCT ID: NCT05261269
Status: COMPLETED
Last Update Posted: 2023-12-13
First Post: 2022-02-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Dose-escalation Study of the Safety and Pharmacology of DAN-222 in Subjects With Metastatic Breast Cancer
Sponsor: Dantari, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module